Scientific Program
October 1, 2021
Nurses Program 11:00-13:15 CEST
Supported by an unrestricted grant by Ferring Pharmaceuticals
| Welcome Milton Leong, Hong Kong, Zeev Shoham, Israel | |
| 11:00-11:15 | Session 1: Fertility Nursing past and present |
| Judith Smith, UK | |
| 11:15-11:30 |
Session 2: The role of the Fertility Nurse in the UK, education, and development now |
| Katie Best, UK | |
| 11:30-11:50 | Session 3: The neuroendocrinology control of the reproductive system |
| Dominique de Ziegler, France | |
| 11:50-12:35 | Session 4: The protocols for ovarian stimulation |
| Ariel Weissman, Israel | |
| 12:35-12:50 | Session 5: The experience of the nurse from OR |
| Preparing for OPU, Set-up Tips for Success Sophie Hall – Registered Nurse, Royal Women’s Hospital, Sydney, Australia An Egg’s Journey, from OPU to Laboratory Sarah Dalati – Senior Embryologist, Fertility & Research Centre, Sydney, Australia |
|
| 12:50-13:15 | Session 6: The different procedures that take place in the IVF Lab |
| Jessica Bailey, USA |
Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)
| Welcome Milton Leong, Hong Kong, Botros Rizk, USA, Zeev Shoham, Israel | |
| 14:00-14:25 | Special lecture |
| 14:00-14:25 | The Corona 19 virus and the reproductive organs. Summarizing almost two years of unknown consequences and different guidelines. What information are we still missing? Virgilio Novero, Philippines |
| 14:25-16:00 | Session 1: Embryo formation and development |
| 14:25-14:50 | How the concept of eugenics has evolved from idea to reality David Albertini, USA |
| 14:50-15:30 | Imaging how cells change their fate, shape and position to form the preimplantation embryo Nicolas Plachta, USA |
| 15:30-16:00 | Reproducing and the End of Life: Genesis through Deuteronomy, α to Ω Gerald Schatten, USA |
| 16:00-16:30 | Special Lecture |
| 16:00-16:30 | For receiving special honor by Her Majesty, the Queen of the United Kingdom Commanders of the Order of the British Empire (CBE) for Services to Female Reproductive Biology A personal Journey towards developing In Vitro Follicle Growth Systems (IVG): It takes a community Evelyn Telfer, UK |
| 16:30-18:30 | Session 2: Innovation In the field of Reproductive Medicine |
| 16:30-17:10 | Genetic innovations from the standpoint of Precision Medicine in Reproductive Medicine Carlos Simon, Spain |
| 17:10-17:45 | Artificial intelligence technologies in ART: Future role Charles Bormann, USA |
| 17:45-18:05 | The future is bright, the future is frozen Charles Kingsland, UK |
| 18:05-18:30 | Evidence-based ET timing Tsafrir Kolatt, Israel |
| 18:30-19:35 | Session 3: Improving efficacy and efficiency in your clinic Supported by Vitrolife |
| 18:30-18:55 | Optimization of oocyte collection: efficacy and safety William Ledger, Australia |
| 18:55-19:20 | Workflow efficiency related to iDAScore Marcos Meseguer, Spain |
| 19:20-19:35 | Peculiarities of work with EmbryoGlue for successful results Olga Morozova, Russia |
| Closing remarks of the first day |
October 2, 2021
Nurses Program 11:00-13:00 CEST
Supported by an unrestricted grant by Ferring Pharmaceuticals
| 11:00-11:20 | Session 7: The role of monitoring the stimulation treatment |
| Seang Lin Tan, Canada | |
| 11:20-11:50 |
Session 8: The journey of the sperm |
| Sherman Silber, USA | |
| 11:50-12:20 | Session 9: Genetics for nurses |
| Discuss basic genetic concepts, recognize common genetic tests in the ART setting, evaluate common genetics issues that may arise in the ART setting and when referrals are indicated Yaron Yuval, Israel |
|
| 12:20-12:50 | Session 10: Making eggs and sperm from a person’s skin cells |
| Sherman Silber, USA |
Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)
| 14:00-14:20 | GE Symposium |
| 14:00-14:20 | More Than Just Follicles – A Practical Guide to Expanding Ultrasound Use in Your Practice Melissa Bunk, USA |
| 14:20-15:45 | Session 4: Treating the unfavorable prognosis patient in IVF Organized by: The Center for Human Reproduction (CHR), New York, N.Y Introduction by Norbert Gleicher, USA |
| 14:20-14:50 | 20 years of IVF stagnation, a main reason being automatic rejection of women above age 42-43 for autologous IVF Norbert Gleicher, USA |
| 14:50-15:10 | Androgen-induced epigenetic modulations in the ovary Aritro Sen, USA |
| 15:10-15:25 | Why IVF cycles in poor prognosis patients must be highly individualized David H. Barad, USA |
| 15:25-15:45 | Why poor prognosis patients should be the last candidates for PGT-A Pasquale Patrizio, USA |
| 15:45-16:10 | Special Lecture |
| 15:45-16:10 | Customer Experience: Utilizing a highly accurate, efficient, and reliable assay for the detection of aneuploidy in pre-implantation embryo biopsy samples Adam Goodman, USA |
| 16:10-17:15 | Session 5 Introduction by Botros Rizk, USA |
| 16:10-16:35 | The chamber of secrets: Indicator for embryo transfer success Charles Kingsland, UK |
| 16:35-17:00 | Plasticity of the human embryo: lessons learned from time-lapse imaging in the IVF lab and its synergies with PGT Alison Campbell, UK |
| 17:00-17:15 | Immortality through ART: How ART combined with space research will change the future of humanity Ertug Kovanci, USA |
| 17:15-17:45 | Session 6: Advanced maternal age and complications of pregnancy Introduction by Alon Ben Arie, Israel |
| 17:15-17:45 | Challenges of being pregnant above the age of 50 Edi Vaisbuch, Israel |
| 17:45-18:05 | Vaginal Progesterone to Prevent Preterm Birth Roberto Romero, USA |
| 18:05-19:15 | Session 7: Endometriosis and infertility |
| 18:05-18:25 | The use of oral GnRH antagonists Ziv Tsafrir, Israel |
| 18:25-18:45 | The most promising data of using progetogens among women with endometriosis and infertility Svetlana Dubrovina, Russia |
| 18:45-19:15 | Endometriosis: Surgical treatment for reproduction Olivier Donnez, Belgium |
| 19:15-19:45 | Session 8: Special lecture |
| 19:15-19:45 | Navigating Patients’ Hopes and Fertility Reality: Psychological Mechanisms to the Rescue Talya Miron-Shatz, Israel |
| Closing remarks of the second day |
October 3, 2021
Nurses Program 12:30-13:40 CEST
Supported by an unrestricted grant by Ferring Pharmaceuticals
| 12:30-12:55 | Session 11: Fertility preservation |
| Marie-Madeleine Dolmans, Belgium | |
| 12:55-13:20 | Session 12: PCOS an update: History, definition, and treatment |
| Raoul Orvieto, Israel | |
| 13:20–13:40 | Session 13: The Challenging Role of the IVF Nurse |
| Carol Lesser, USA | |
| Closing remarks: Milton Leong, Hong Kong and Zeev Shoham, Israel |
Main Program – starting at 14:00 CEST
(Paris – 14:00, Cairo 15:00, Hong Kong – 20:00, San Diego – 05:00, New York – 08:00, Buenos Aires – 09:00)
| 14:00-15:45 | Session 9: Why most add-ons hurt IVF outcomes Organized by: The International Do No Harm Group in IVF (IDNHG-IVF) Introduction by Norbert Gleicher, USA |
| 14:00-14:25 | Defining add-ons and how they should be introduced to IVF Joyce Harper, UK |
| 14:25-14:55 | Extended culture to blastocyst, add-on or routine IVF practice? Demian Glujovsky, Argentina |
| 14:55-15:20 | PGT-A, the most consequential add-on to IVF of them all Raoul Orvieto, Israel |
| 15:20-15:45 | Embryo banking/freezing another unsupported fashion of the moment Norbert Gleicher, USA |
| 15:45-16:40 | Session 10: The sperm Introduction by Botros Rizk, USA, Zeev Shoham, Israel |
| 15:45-16:05 | Intracytoplasmic sperm injection versus conventional in-vitro fertilization in couples with infertility in whom the male partner has normal total sperm count and motility Ben Mol, Australia |
| 16:05-16:25 | Management of azoospermia and ART Medhat Amer, Egypt |
| 16:25-16:40 | Molecular profiling of spermatozoa opens a new way to explore male infertility Nino Guy Cassuto, France |
| 16:40-17:55 | Session 11: New perspective on the Luteal phase support Introduction by Ariel Weissman, Israel |
| 16:40-17:00 | Progesterone free luteal support in IVF Shahar Kol, Israel |
| 17:00-17:20 | GnRh analog as a sole luteal support in ART treatments Itai Bar-Hava, Israel |
| 17:20-17:35 | Should women receive luteal support following natural cycle frozen embryo transfer? Yossi Mizrachi, Australia |
| 17:35-18:05 | Discussion |
| 18:05-19:40 | Session 12: New approach to IVF |
| 18:05-18:25 | A new approach makes Saline Infusion Sonography (SIS) simpler and more user friendly Dominique de Ziegler, France |
| 18:25-18:50 | Ovarian stimulation for IVF Botros Rizk, USA |
| 18:50-19:20 | Mini/IVF Sherman Silber, USA |
| 19:20-19:40 | The application of progestin-primed ovarian stimulation (PPOS) in women with polycystic ovarian syndrome Kuang Yanping, China |
| 19:40-21:00 | Session 13: Next generation ART Organized by the Latin-American Association for Reproductive Medicine (ALMER) Introduction by Ricardo Loret de Mola, USA & Marcelo Barrionuevo, USA |
| 19:40-20:05 | New biomarkers of embryo development Gianpiero Palermo, USA |
| 20:05-20:30 | Future of PGT Nathan Treff, USA |
| 20:30-21:00 | Artificial intelligence in ART Cristina Hickman, UK |
| 21:00-21:25 | Session 14: How can we work with the social media: practical ideas for improving patient communications Organized by Vanguard Communications, USA |
| 21:00-21:15 | Five ways to Optimize Patient Communications to Optimize Outcomes Stephanie Wilson, USA and Selene Neuburg, USA |
| 21:15-21:25 | Fighting Fertility Myths & Misinformation on social media Ron Harman King, USA |
| 21:25-21:30 | Closing remarks Milton Leong, Hong Kong, Botros Ritz, USA, Zeev Shoham, Israel |